<DOC>
	<DOCNO>NCT00235417</DOCNO>
	<brief_summary>The purpose study determine whether intracoronary bone marrow transplantation improve leave ventricular ejection fraction patient severe ischemic heart failure option standard therapy ( revascularization drug ) .</brief_summary>
	<brief_title>Stem Cell Therapy Chronic Ischemic Heart Failure</brief_title>
	<detailed_description>Despite standard therapy ( revascularization drug ) , patient severe ischemic heart failure high morbidity mortality . The purpose study determine whether intracoronary transfer autologous bone marrow cell induce angiogenesis , subsequently improve regional myocardial perfusion , finally result improve systolic diastolic leave ventricular function patient severe ischemic heart failure . 35 patient stable left ventricle function - four month interval - receive two treatment bone marrow transplantation intracoronary vessel supply dysfunctional myocardial territory . Echocardiography perform three time prior ( four two month ) two time ( four eight month ) therapy . It non-randomised trial , patient enter control .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>1 . Severe ischemic heart failure option standard therapy ( revascularization drug ) , 2 . Stable leave ventricular ejection fraction &lt; 40 % , 3 . CCS class 23 and/or NYHA class 23 , 4 . Signed informed consent . 1 . Implantation pacemaker ( include implantable cardioverter defibrillator [ ICD ] biventricular pacing ) , 2 . Acute myocardial infarction within 3 month , 3 . Atrial fibrillation , 4 . Severe comorbidity could impact patient 's shortterm survival ( include primary hematologic disorder )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Bone Marrow Transplantation</keyword>
</DOC>